Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$2.23B |
| 2 |
Wells Fargo
WFC
|
+$2.16B |
| 3 |
NVIDIA
NVDA
|
+$1.63B |
| 4 |
American Express
AXP
|
+$864M |
| 5 |
Amazon
AMZN
|
+$791M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.71B |
| 2 |
Chubb
CB
|
+$1.49B |
| 3 |
ConocoPhillips
COP
|
+$1.33B |
| 4 |
Microsoft
MSFT
|
+$1.32B |
| 5 |
Advanced Micro Devices
AMD
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.06% |
| 2 | Healthcare | 20.38% |
| 3 | Financials | 14.37% |
| 4 | Consumer Discretionary | 9.45% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Krystal Biotech
KRYS
$9.63B
| $1.66M | ﹤0.01% |
+9,308
| New | +$1.29M |
|
|
WBA
1477
DELISTED
Walgreens Boots Alliance
WBA
| $1.66M | ﹤0.01% |
76,307
+18,046
| +31% | +$401K |
|
1478
Keysight
KEYS
$57.9B
| $1.65M | ﹤0.01% |
10,569
+1,393
| +15% | +$214K |
|
1479
W.P. Carey
WPC
$16.3B
| $1.65M | ﹤0.01% |
29,205
+1,731
| +6% | +$104K |
|
1480
Lexicon Pharmaceuticals
LXRX
$1.07B
| $1.65M | ﹤0.01% |
+686,418
| New | +$1.47M |
|
|
ATXS
1481
DELISTED
Astria Therapeutics
ATXS
| $1.63M | ﹤0.01% |
+116,057
| New | +$1.45M |
|
1482
Iovance Biotherapeutics
IOVA
$2.78B
| $1.63M | ﹤0.01% |
110,219
-44,926
| -29% | -$523K |
|
1483
Fulcrum Therapeutics
FULC
$284M
| $1.63M | ﹤0.01% |
+172,660
| New | +$1.54M |
|
1484
Clorox
CLX
$12.8B
| $1.63M | ﹤0.01% |
10,631
+8,402
| +377% | +$1.25M |
|
1485
CALL
Antero Resources
AR
$10.8B
| $1.62M | ﹤0.01% |
+5,381
| New | +$130K |
|
1486
C4 Therapeutics
CCCC
$400M
| $1.61M | ﹤0.01% |
+197,109
| New | +$1.53M |
|
|
VBNK
1487
VersaBank
VBNK
$620M
| $1.61M | ﹤0.01% |
151,883
+27,600
| +22% | +$306K |
|
1488
Starwood Property Trust
STWD
$5.85B
| $1.61M | ﹤0.01% |
79,120
+12,858
| +19% | +$260K |
|
1489
Altimmune
ALT
$589M
| $1.6M | ﹤0.01% |
+156,914
| New | +$1.6M |
|
1490
AES
AES
$10.5B
| $1.59M | ﹤0.01% |
88,830
-8,303,868
| -99% | -$139M |
|
1491
Invitation Homes
INVH
$18B
| $1.59M | ﹤0.01% |
44,560
+2,219
| +5% | +$75.1K |
|
1492
Thomson Reuters
TRI
$43.7B
| $1.55M | ﹤0.01% |
9,816
+6,618
| +207% | +$1.03M |
|
1493
Biohaven
BHVN
$2.15B
| $1.55M | ﹤0.01% |
28,277
+14,411
| +104% | +$714K |
|
1494
Oric Pharmaceuticals
ORIC
$1.34B
| $1.54M | ﹤0.01% |
111,973
+39,576
| +55% | +$470K |
|
1495
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $1.54M | ﹤0.01% |
+47,000
| New | +$1.53M |
|
1496
Biomea Fusion
BMEA
$91.1M
| $1.53M | ﹤0.01% |
102,534
+16,998
| +20% | +$280K |
|
1497
Coastal Financial
CCB
$665M
| $1.52M | ﹤0.01% |
39,120
-8,829
| -18% | -$349K |
|
1498
Teradata
TDC
$2.53B
| $1.51M | ﹤0.01% |
39,145
+14,037
| +56% | +$592K |
|
1499
Banco de Chile
BCH
$21.3B
| $1.49M | ﹤0.01% |
66,970
-213,746
| -76% | -$4.81M |
|
1500
CNA Financial
CNA
$14.2B
| $1.49M | ﹤0.01% |
32,713
+7,769
| +31% | +$343K |
|
Similar funds
Wellington Management Group's Q1 2024 Portfolio in Review
As of Q1 2024, Wellington Management Group held 2,007 positions worth $564B, up 5.2% from $536B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Wellington Management Group withdrew a net $17.2B in Q1 2024, closing 120 positions and reducing 834 holdings. Its most notable exit was Flagstar Bank National Association, an estimated $640M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in Flutter Entertainment worth $505M.
- Wellington Management Group's largest Q1 2024 buy was Flutter Entertainment: 2,532,472 shares worth $505M.
- Wellington Management Group added most to ExxonMobil in Q1 2024, an estimated $2.23B increase.
- Wellington Management Group's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.71B.
- Wellington Management Group fully exited Flagstar Bank National Association in Q1 2024, selling an estimated $640M.
- Wellington Management Group's ten largest holdings make up 21% of its $564B portfolio in Q1 2024.
- Wellington Management Group opened 188 new positions and closed 120 in Q1 2024.
- Wellington Management Group's portfolio value rose 5.2% quarter-over-quarter to $564B.
Based on Wellington Management Group's 13F filing for Q1 2024, filed 15 May 2024.